Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.46 USD | +1.40% | +0.18% | -2.24% |
Jun. 03 | Royalty Pharma Prices $1.5 Billion Debt Offering | MT |
Jun. 03 | Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes | CI |
Financials (USD)
Sales 2024 * | 2.64B | Sales 2025 * | 2.93B | Capitalization | 12.41B |
---|---|---|---|---|---|
Net income 2024 * | 942M | Net income 2025 * | 1.1B | EV / Sales 2024 * | 6.92 x |
Net Debt 2024 * | 5.87B | Net Debt 2025 * | 6B | EV / Sales 2025 * | 6.3 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.1
x | Employees | - |
Yield 2024 * |
3.28% | Yield 2025 * |
3.55% | Free-Float | 85.52% |
Latest transcript on Royalty Pharma plc
1 day | +1.40% | ||
1 week | +0.18% | ||
Current month | +0.18% | ||
1 month | -1.82% | ||
3 months | -9.58% | ||
6 months | -3.89% | ||
Current year | -2.24% |
Managers | Title | Age | Since |
---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 95-12-31 |
Terrance Coyne
DFI | Director of Finance/CFO | 42 | 09-12-31 |
Arthur McGivern
CIO | Chief Investment Officer | - | 22-10-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Errol de Souza
BRD | Director/Board Member | 70 | 20-05-31 |
David Hodgson
BRD | Director/Board Member | 67 | 22-06-22 |
Ted Love
BRD | Director/Board Member | 65 | 20-07-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.98% | 208 M€ | +13.89% | - | |
0.51% | 5 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 27.46 | +1.37% | 2,436,970 |
24-06-06 | 27.09 | +0.33% | 1,702,226 |
24-06-05 | 27 | -0.07% | 2,203,632 |
24-06-04 | 27.02 | +0.67% | 2,156,234 |
24-06-03 | 26.84 | -2.08% | 3,552,928 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.24% | 12.41B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.28% | 248B | |
-1.80% | 219B | |
+10.89% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- RPRX Stock